EssilorLuxottica Launches SWITCH Summit to Position Eyewear as Healthcare Platform
Event summary
- EssilorLuxottica hosted its inaugural SWITCH: Vision Innovation Summit from March 9–11, 2026, in Orlando, Florida, with over 1,000 attendees.
- The summit explored AI-powered smart eyewear, neuroscience-driven vision personalization, and oculomics for early disease detection.
- EssilorLuxottica highlighted its Stellest® lenses for myopia management and Varilux® lenses for presbyopia.
- The company aims to make SWITCH an annual event, with upcoming summits in EMEA and Asia scheduled for April 13–15, 2026, in Monaco.
The big picture
EssilorLuxottica's SWITCH summit underscores the company's strategic pivot to position eyewear as a central platform for healthcare, connectivity, and human potential. The event highlights the growing trend of integrating AI and medical science into wearable technology, potentially expanding the vision care industry into new frontiers. With a global footprint and significant revenue, EssilorLuxottica is well-positioned to capitalize on these emerging trends, but success will depend on execution and regulatory adaptability.
What we're watching
- AI Integration
- How EssilorLuxottica will leverage AI to drive personalization and healthcare applications in eyewear.
- Market Expansion
- Whether the SWITCH summit can position EssilorLuxottica as a leader in the convergence of vision care and broader healthcare.
- Regulatory Dynamics
- The pace at which regulatory frameworks will adapt to the integration of health diagnostics into consumer eyewear.
Related topics